...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Analysis of the phase solubility diagram of a phenacetin/competitor/beta-cyclodextrin ternary system, involving competitive inclusion complexation.
【24h】

Analysis of the phase solubility diagram of a phenacetin/competitor/beta-cyclodextrin ternary system, involving competitive inclusion complexation.

机译:非那西丁/竞争剂/β-环糊精三元体系的相溶度图分析,涉及竞争性包合物。

获取原文
获取原文并翻译 | 示例
           

摘要

The competitive inclusion complexations in the ternary phenacetin/competitors/beta-cyclodextrin (beta-CyD) systems were investigated by the solubility method, where m-bromobenzoic acid (m-BBA) and o-toluic acid (o-TA) were used as competitors. The solubility changes of the drug and competitors as a function of beta-CyD concentration in the ternary systems were formulated using their stability constants and intrinsic solubilities. The decrease in solubility of phenacetin by the addition of competitors could be quantitatively simulated by the formulation, when both drug and competitor give A(L) type solubility diagrams. On the other hand, when one of the guests gives a B(S) type solubility diagram, its solubility change was clearly reflected in that of the another guest, i.e., phenacetin gave an A(L) type solubility diagram in the binary phenacetin/beta-CyD system and o-TA gave a B(S) type diagram in the binary o-TA/beta-CyD system, but in the ternary phenacetin/o-TA/beta-CyD system, a new plateau region appeared in the original A(L) type diagram of phenacetin. This was explained by the solubilization theory of Higuchi and Connors. The solubility analysis of the ternary drug/competitor/CyD systems may be particularly useful for determination of the stability constant of a drug whose physicochemical and spectroscopic analyses are difficult, because they can be calculated by monitoring the solubility change of a competitor, without monitoring that of a drug. Furthermore, the present results suggest that attention should be paid to the type of the phase solubility diagram, as well as the magnitude of the stability constant and the solubility of the complex, for a rational formulation design of CyD complexes.
机译:通过溶解度方法研究了非那西丁/竞争者/β-环糊精(β-CyD)系统中的竞争性包合物,其中间溴苯甲酸(m-BBA)和邻甲苯甲酸(o-TA)竞争对手。使用它们的稳定性常数和固有溶解度,确定了药物和竞争剂在三元体系中的溶解度变化与β-CyD浓度的关系。当药物和竞争者均给出A(L)型溶解度图时,通过添加竞争剂可降低非那西丁溶解度的降低,可通过配方进行定量模拟。另一方面,当其中一个客体给出B(S)型溶解度图时,其溶解度变化在另一客体中清楚地反映出来,即非那西丁在二元非那西丁/中给出了A(L)型溶解度图。 beta-CyD系统和o-TA在二元o-TA / beta-CyD系统中给出了B(S)型图,但在三元非那西丁/ o-TA / beta-CyD系统中,新的高原区域出现在非那西丁的原始A(L)型图。 Higuchi和Connors的增溶理论对此进行了解释。三元药物/竞争者/ CyD系统的溶解度分析对于确定物理化学和光谱分析困难的药物的稳定性常数可能特别有用,因为可以通过监测竞争者的溶解度变化来计算它们,而无需监测一种药物。此外,目前的结果表明,对于CyD配合物的合理配方设计,应注意相溶解度图的类型以及稳定性常数和配合物的溶解度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号